← Leaderboards
Anthony M Downs
Emory University
$319,766
Attributed
$319,766
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $184.7K · FY2018–25$200K$150K$100K$50K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$319,766 · 2
By mechanism
K01$184,706 · 1
F31$135,060 · 1
Top collaborators
No co-investigators on record.
Most similar at Emory University
Same institution · by research overlap
- Ellen J. Hess$12,190,689
- Daniel F. Manvich$1,349,233
- Mahlon R Delong$4,829,158
- Maria C Santana$86,697
- Eric J Sorscher$13,371,665
Others in their field
Other Emerging Leaders on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Lynn Briscoe · Leidos Biomedical Research, Inc.$97,151,761
- Beth Baseler · Leidos Biomedical Research, Inc.$87,027,148
Research focus
Pharmaceutical PreparationsNeuronsPeriodicityScanningNew Therapeutic TargetInterneuronsNeurotransmissionPatternReceptor SignalingFunctional DisorderEffective TherapyOralBrainAnti-CholinergicsGlutamic AcidFocal DystoniasExperimental StudyExtracellularInheritedCholinergicDyskinetic SyndromeDystoniaBasal GangliaCell Type
Grant awards (4)
Impact of fentanyl consumption on noradrenergic plasticity in the basolateral amygdala$184,706
K01 · FY2025 · DA · contact PI
Selective muscarinic receptor antagonists as therapeutics in dystonia$45,520
F31 · FY2020 · NS · contact PI
Selective muscarinic receptor antagonists as therapeutics in dystonia$45,016
F31 · FY2019 · NS · contact PI
Selective muscarinic receptor antagonists as therapeutics in dystonia$44,524
F31 · FY2018 · NS · contact PI